Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,973 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Intracerebral hemorrhage location and outcome among INTERACT2 participants.
Delcourt C, Sato S, Zhang S, Sandset EC, Zheng D, Chen X, Hackett ML, Arima H, Hata J, Heeley E, Al-Shahi Salman R, Robinson T, Davies L, Lavados PM, Lindley RI, Stapf C, Chalmers J, Anderson CS; INTERACT2 Investigators. Delcourt C, et al. Among authors: chalmers j. Neurology. 2017 Apr 11;88(15):1408-1414. doi: 10.1212/WNL.0000000000003771. Epub 2017 Feb 24. Neurology. 2017. PMID: 28235817 Free PMC article. Clinical Trial.
Effects of an angiotensin-converting enzyme inhibitor-based regimen on pneumonia risk.
Ohkubo T, Chapman N, Neal B, Woodward M, Omae T, Chalmers J; Perindopril Protection Against Recurrent Stroke Sutdy Collaborative Group. Ohkubo T, et al. Among authors: chalmers j. Am J Respir Crit Care Med. 2004 May 1;169(9):1041-5. doi: 10.1164/rccm.200309-1219OC. Epub 2004 Feb 27. Am J Respir Crit Care Med. 2004. PMID: 14990394 Clinical Trial.
Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region.
Rodgers A, Chapman N, Woodward M, Liu LS, Colman S, Lee A, Chalmers J, MacMahon S; Perindopril Protection against Recurrent Stroke Study Collaborative Group. Rodgers A, et al. Among authors: chalmers j. J Hypertens. 2004 Mar;22(3):653-9. doi: 10.1097/00004872-200403000-00030. J Hypertens. 2004. PMID: 15076173 Clinical Trial.
Effects of perindopril-based blood pressure lowering and of patient characteristics on the progression of silent brain infarct: the Perindopril Protection against Recurrent Stroke Study (PROGRESS) CT Substudy in Japan.
Hasegawa Y, Yamaguchi T, Omae T, Woodward M, Chalmers J; PROGRESS CT Substudy Investigators. Hasegawa Y, et al. Among authors: chalmers j. Hypertens Res. 2004 Mar;27(3):147-56. doi: 10.1291/hypres.27.147. Hypertens Res. 2004. PMID: 15080373 Free article. Clinical Trial.
Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials.
Turnbull F, Neal B, Algert C, Chalmers J, Chapman N, Cutler J, Woodward M, MacMahon S; Blood Pressure Lowering Treatment Trialists' Collaboration. Turnbull F, et al. Among authors: chalmers j. Arch Intern Med. 2005 Jun 27;165(12):1410-9. doi: 10.1001/archinte.165.12.1410. Arch Intern Med. 2005. PMID: 15983291
Perindopril-based blood pressure-lowering reduces major vascular events in patients with atrial fibrillation and prior stroke or transient ischemic attack.
Arima H, Hart RG, Colman S, Chalmers J, Anderson C, Rodgers A, Woodward M, MacMahon S, Neal B; PROGRESS Collaborative Group. Arima H, et al. Among authors: chalmers j. Stroke. 2005 Oct;36(10):2164-9. doi: 10.1161/01.STR.0000181115.59173.42. Epub 2005 Sep 1. Stroke. 2005. PMID: 16141420 Clinical Trial.
1,973 results